Legal Guidance and Research / Experts / Bridget Winters
Bridget Winters#13832

Bridget Winters

Taylor Wessing LLP
Bridget is a Senior Counsel in the Tax & Incentives group, where she provides comprehensive advice across a broad spectrum of corporate transactions. She originally qualified as a tax litigator before transitioning to non-contentious work, bringing ten years of corporate tax expertise to her role.

Her practice focuses particularly on general M&A and private equity transactions, as well as complex cross-border private M&A, joint venture and venture capital arrangements. She works with a diverse client portfolio at Taylor Wessing that spans companies at every stage of their development journey, from innovative start-ups through to established listed entities, representing both UK and international clients.

Her sector experience encompasses the technology and life sciences industries, the evolving energy and renewables sector, and the banking and finance markets, enabling her to provide tailored, commercially-focused advice that addresses the unique challenges and opportunities within each industry.

Practice Area

Panel

  • Contributing Author

Qualified Year

  • 2012

Experience

  • Orrick, Herrington & Sutcliffe (2016 - 2022)
  • Macfarlanes (2015 - 2016)
  • DLA Piper (2010 - 2015)

Qualifications

  • Qualified lawyers transfer test (2013)
  • Law LLB (2005)

Education

  • Inns of Court School of Law (2006)
  • University of Cardiff (2005)

1 Contributions by Bridget Winters

UK life sciences tax: R&D and Patent Box, intangible assets, cross-border transfer pricing and DPT, investment and employee incentives, compliance and environmental taxes
PRACTICE NOTES
UK life sciences tax: R&D and Patent Box, intangible assets, cross-border transfer pricing and DPT, investment and employee incentives, compliance and environmental taxes
This Practice Note outlines key tax considerations for businesses in the life sciences industry, including pharmaceutical, medical technology and biotechnology companies. It examines, among other areas, corporation tax topics such as research and development (R&D) reliefs and the patent box, together with cross-border matters including transfer pricing and investment reliefs... Cross-border framework On 31 January 2020, the UK left EU membership and entered an implementation period during which the EU continued to treat it as a Member State for many purposes. This ended on 31 January 2020, after which EU law and the jurisdiction of the Court of Justice of the European Union largely ceased to apply to the UK. The trading relationship between the UK and the EU is thereafter governed by the EU-UK Trade and Cooperation Agreement... State aid Following the UK’s departure from the EU, the UK is no longer bound by EU State aid law, which requires the European Commission’s advance approval of State aid. A number of the regimes described below (in particular, those described...
Tax
Expert page AD
If you expected to see yourself on this page, click here.